Currently, chronic traumatic encephalopathy (CTE) is widely recognized as a neurodegenerative syndrome caused by constant exposure to events of acceleration and deceleration. CTE produces a myriad of neurological alterations in both the short-and long term; some of these alterations disturb the homeostasis of the central nervous system, and trigger several behavioral and cognitive deficits. The pathology of CTE resembles that of Alzheimer's, Parkinson's and Huntington's disease (among many others), which are characterized by the important role of the immune response in the development of the disease and the deposition of proteins, such as amyloid beta and tau. In the present article, we review the succession of events that develop after exposure to acceleration/deceleration events, and how such events affect the distinct cellular types in the central nervous system and their role in the activation of the immune system. We also review how the activation of the immune system affects mechanisms, such as neurogenesis and neurodegeneration, and how this in turn could generate the behavioral and cognitive deficits associated with this pathology.
Introduction
Traumatic brain injury (TBI) is defined as the alteration of cerebral functions or as the presence of evident neurological pathologies derived from the action of external forces, either originating from blows, acceleration/deceleration events, foreign objects penetration or blast impacts. 1 Chronic traumatic encephalopathy (CTE) is currently recognized as a neurodegenerative type syndrome. 2, 3 Recent post-mortem findings show that CTE can affect a wider population than originally thought, in particular those athletes involved in contact sports and those individuals with a history of military combat. 4 
Epidemiology
It is estimated that approximately 17% of retired professional boxers present CTE. 5 Further studies have reported that 90% of neuropathologically confirmed CTE cases occurred in athletes that had practiced contact sports. 6 In 1990, the first histopathological diagnosis of CTE was carried out in a non-boxing woman, who had undergone repeated physical abuse, and in later years developed a dementia syndrome clinically and histopathologically compatible with those cases reported for decades in contact sports athletes (boxers). 7 In a post-mortem study of contact sports athletes it was observed that 71% had neuropathological changes indicating chronic encephalopathy. In other post-mortem studies of individuals with a history of repetitive mild TBI, 80% presented chronic encephalopathy.
defined as a pathological syndrome as a result of the focal or diffuse destruction, macro-or microscopic, of the cerebral tissue. Both present primary and secondary damage, but they differ in that the damage is neither progressive nor neurodegenerative, in contrast to chronic traumatic encephalopathy. 8 Chronic traumatic encephalopathy is classified as a tauopathy characterized by the accumulation of the hyperphosphorylated tau protein in neurons and astrocytes, presenting in the form of neuritic threads around small blood vessels of the cortex, typically at the depths of the sulci. 6, 9 Chronic traumatic encephalopathy resembles other neurodegenerative diseases clinically and pathologically, considered as proteinopathies including Alzheimer's disease and frontotemporal lobar degeneration. 10 For its diagnosis, there are several criteria: the first were proposed by B. Jordan and were developed specifically to represent the probability of an underlying neuropathology. Four diagnostic classifications are used: defined CTE, probable, possible and nonprobable. The defined CTE refers to any neurological process consistent with the clinical presentation together with its pathological confirmation; probable CTE is characterized by diverse clinical affections clinically distinguishable from any pathological process; possible CTE can be potentially explained by other neurological alterations; and improbable CTE includes any neurological process not consistent with the clinical description of CTE and can be explained by a physiopathological process not related to the brain. 3 
Primary and secondary damage
Chronic traumatic encephalopathy is a multifactorial phenomenon with diverse events in the same temporal line; these events have been classified in two categories: (i) primary damage, which implicates events that occur in the first minutes after the TBI; and (ii) secondary damage, which encompasses events occurring hours or days after the injury. 1, 8, 11 In the case of chronic TBI, we can also consider the changes occurring years after, even when the trauma has ceased, and these mechanisms lead to neurodegeneration. The events referred to in primary damage involve those that generate tissular damage (hematoma, concussion, diffuse axonal damage etc.), as well as the immediate cellular and subcellular consequences of the aforementioned events. As a consequence, one of the most common cellular effects of TBI is the mechanical alteration of the neuron, 12 including the mechanoporation of the membrane and the axolemma, which is a traumatic defect in the membrane by which proteins separate from the lipidic bilayer that constitutes the membrane. 12 This can induce an imbalance in the passing of ions, and this defect will last according to the degree of the injury.
At the subcellular level (in the particular case of ionic homeostasis), primary damage strongly influences Ca 2+ homeostasis, which is a known second messenger, hence its disruption generates a wide scope of negative effects in the brain, 13 such as the deregulated release of neurotransmitters (mainly glutamate), which unchains the additional release of Ca 2+ found in the intracellular reserves 14 giving way to reactions that can lead to a cytotoxic injury, oxidative stress, 15 proteolysis 16 and, finally, to programmed (apoptosis) and not programmed (necrosis) cell death. 17, 18 Derived from the TBI-induced primary damage events are the secondary effects on the brain's physiology; these effects are known as secondary damage, and occur on a greater temporal scale than those of primary damage. 12 The secondary damage processes can include traumatic hematomas, focal or diffuse brain edema, elevated intracranial pressure, obstructive hydrocephaly, hypoxia, ischemic lesion and infections. 14 This type of damage can become severe in the presence of a pre-existing pathology.
Short-and long-term consequences of TBI
Each TBI case represents a unique set of injuries of varied location and intensity; however, shared consequences and pathologies have been characterized for most TBI cases. The severity and duration of the traumatic event will largely dictate the nature of consequences, which can be classified in short-and long-term consequences. Short-term consequences are derived from the impact and initial damage to the encephalic tissue, and can comprise loss of consciousness, amnesia, hypoxia, seizures and death. Long-term consequences implicate important changes in both the cognition and personality of the individuals; 14 this is due to the permanent damage in key areas of the brain, such as the dorsolateral prefrontal cortex, the orbitofrontal cortex, the temporal cortex, the amygdala and the cerebellum, among others. Damage in these areas has been related with deficits in working memory, short-and long-term memory, attention, processing velocity, disinhibition of social behavior, alterations in the motivation system, depression, substance abuse, post-traumatic stress syndrome, and so on. 19 The relationship between the short-term and the longterm effects of TBI in promoting a CTE are summarized in Figure 1 .
Neuronal damaged induced by TBI
As mentioned, exposure to acceleration/deceleration events in the brain region produce different short-and long-term alterations, which derive from damage to the nervous tissue, mainly, but are not limited to the neuronal cells responsible for transmitting the nerve impulses and whose loss leads to the wide symptomatology observed in TBI. This loss is mediated by different mechanisms of physical and chemical nature.
One of the main (and most immediate) consequences of a traumatic event at the brain level is the disruption of the plasmatic membrane of the neurons in a mechanism named mechanoperation. 20 The mechanoporation of the plasmatic membrane leads to an increase in the cell membrane permeability and its subsequent ionic imbalance, which promotes the release of neurotransmitters (due to the entrance of Ca 2+ ) to the synaptic cleft, mainly of glutamate. 20 In parallel, the mechanoporation produced by physical damage and exposure to traumatic events can generate an ischemic brain environment, 21 where the supply of oxygen and glucose to the brain is reduced; 22 a situation that can give way to events influencing cell damage.
In an ischemic environment, H + ions tend to accumulate in the cytoplasm, this condition (known as cellular acidosis) is exacerbated by the production of ions derived from glycolysis; 23 metabolic route of adenosine triphosphate production that dominates in oxygen-limiting situations, together with this, the net production of adenosine triphosphate diminishes. 22 This situation gives rise to the inhibition of the Na + -Ca 2+ exchanger, which is responsible for maintaining normal concentrations of both ions; its inhibition results from the increase of intracellular Ca 2+ concentration. 23, 24 The increase in intracellular Ca 2+ (a product of mechanoporation and acidosis) will promote an exaggerated release of excitatory amino acids (particularly glutamate), which will lead to cell death in an event known as excitotoxicity. 25 Excitotoxicity induces cell death by promoting the synthesis of reactive oxygen species, which are produced by the mitochondrion in an attempt to compensate for the massive entrance of Ca 2+ (which increases due to the proteolytic inactivation of the Na + -Ca 2+ exchanger) 24, 26 to the cell, and because of the nicotinamide adenine dinucleotide oxygenase, cyclooxygenase and lipoxygenase enzymes; 27 the latter group of enzymes is of particular relevance, because they promote the action of the Bid protein, which is the mediator of the formation of mitochondrial pores and an inducer of apoptosis.
28 Figure 1 The relationship of the short-term and the long-term effects produced by traumatic brain injury are presented. The exposure to acceleration/deceleration events produced by a variety of stimuli promotes both mechanical and chemical damage in the brain tissue. This (primary) damage is produced in lapses encompassing only a few seconds to some minutes; and in turn induces several chemical cascades that conclude with the onset of the secondary damage. Finally, although the secondary damage lasts hours to days, it can produce (along with several other exposures to traumatic events) the onset of several neurodegenerative events that relate with the cognitive and behavioral deficits classically present in chronic traumatic encephalopathy. TDP-43, TAR DNA-binding protein 43. Together with the action of calcium on reactive oxygen species production, this ion influences diverse proteins, such as caspases, phospholipases and calpains, which promote damage and cell death.
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Mechanisms of axonal damage
In addition to the damage caused in neurons as a whole, there are damaging mechanisms that act specifically on the axons because of their particular architecture; these mechanisms affect their functionality and neurotransmission, aside from being a bad prognosis sign in patients that present it, as it correlates directly with the development of CTE. 30, 31 Similar to the physical forces that generate the mechanoporation in neurons, the impacts produced in the encephalic area and the acceleration/deceleration that accompanies them generate ruptures in the axons and, occasionally, separation of the axon itself (primary axotomy), an event known as diffuse axonal injury (DAI). 30 DAI generates multiple changes in the structure of the axon, having some similarity with those events occurring in the other neuronal regions. Similar to the poration of the neuronal membrane, axons undergo ruptures in their surface during DAI, a situation that fosters the unregulated entrance of ions and, with it, the entrance of extracellular fluid leading to axonal swelling; 30, 32 this condition implicates an increase in the axonal diameter in its different regions, aside from an accumulation of organelles along the axon, in particular the mitochondria, which also increase in size. 30 According to computational models, the increase of axonal diameters in different parts along the axon causes difficulties in the conduction of the action potential, if this condition occurs together with demyelination, a complete inhibition of nervous transmission can occur. 32 Together with the previously mentioned changes, during a DAI episode there is degradation, compaction, and dysfunction of the cytoskeleton induced by calpains and caspases (calcium-dependent enzymes), 30 particularly in the amyloid beta, spectrin and tau proteins; 30, 33, 34 tau is of great relevance for the post-mortem identification of possible CTE causes.
The array of events occurring in the axons during a traumatic event can result in the separation of the axon from the cellular soma due to non-strictly mechanical causes, this is known as secondary axotomy and eventually will give rise to a special type of cell death named Wallerian degeneration, 35, 36 this can occur in large neuronal populations affecting large portions of the white matter in a time lapse going from hours to weeks or even months and years. 36, 37 Effect of the trauma on the microglia As a consequence of the damage produced by a traumatic event, multiple inflammatory factors are produced in the cephalic region, which affect not only neurons, but also glial cells such as the microglia. 38 The microglia is part of the innate immune response and consists of resident cells of the encephalic tissue that is constantly found in a "resting" state, monitoring the homeostasis of the tissue. However, when faced with stimuli indicating the presence of tissular damage, the cells of the microglia can change their phenotype to a reactive and pro-inflammatory phenotype (M1-like) or an alternative, neuroprotective phenotype (M2-like); the first being highly inflammatory, whereas the second is fundamentally anti-inflammatory. 38, 39 Activation of the reactive microglia is a neuronal damaging event resulting from the interaction of the microglia with different molecules that are indicators of neuronal damage, such as the superoxide anion, the amyloid beta protein and extracellular nucleotides. [40] [41] [42] Exposure to one or several of these factors promotes the release of different pro-inflammatory molecules, from the microglial cells to the extracellular environment.
Interleukins are a molecular group widely released by the microglia during its activation and they affect cell survival importantly and differently. Interleukins-1-alpha/beta, -6 and -18 play a pro-inflammatory role just like tumor necrosis factor-alpha; these molecules can foster damage to the hematoencephalic barrier, and allow infiltration of cells and molecules from the peripheral circulation. 38, 39 In contrast, interleukins-16 and -8 act as chemokines, attracting more cells from the immune system to the injured site. 43 Interleukins-3, -15, -12 and -2 promote proliferation and differentiation of immune cells. Finally, interleukins-13 and -10 modulate the immune response, suppressing its activity. 43 In parallel to the release of interleukins, the microglia also releases prostaglandins, inflammatory proteins of macrophages, transforming growth factor-beta, oxygen and nitrogen reactive species, complement proteins, and neurotrophic factors, which affect cell survival. 43 Several of these compounds are summarized in Table 1 , along with the stimuli that promote its secretion and the effects produced in the organism. Activation of microglia after a traumatic event can last several years; during this time, the microgliamediated neurodegeneration can persist and give rise to permanent damage in the encephalic tissue. 39, 41, 43 Effect of the trauma on astroglia Astrocytes play diverse roles in the modulation of the nervous functions. They act as structural support, mediators in the uptake and metabolism of neurotransmitters, and as regulators of cellular and molecular traffic toward the encephalon by being part of the hematoencephalic barrier. 43 In addition to the effect of a traumatic event on the neuronal and microglial cells, there are diverse effects on astrocytes.
Astrocytes (like neurons) are susceptible to structural changes when exposed to mechanical forces during the traumatic event. The mechanical stress can produce changes in the permeability of the membrane and eventual death of astrocytes up to 48 h after exposure to mechanical stress. 44 In addition (and like in neurons), the mechanical stress ATP, adenosine triphosphate; BBB, blood-brain barrier; BCGF-1, B-cell growth factor-1; BSF2, B cell stimulatory factor 2; CLMF1, cytotoxic lymphocyte maturation factor 1; CNS central nervous system; CSF-1, colony-stimulating factor-1; CSIF, colony-stimulating factor; CXCL8, CXC ligand 8; DAI, diffuse axonal injury; EGF, epidermal growth factor; FGF, fibroblasts growth factor; IL, interleukin; M-CSF, macrophage colony-stimulating factor; NGF, nerve growth factor; TCGF, T-cell growth factor; TGF-b, transforming growth factor; TNF-b, tumor necrosis factor.
reduces the available energy within the cell (as adenosine triphosphate), which generates the accumulation of intracellular calcium by inhibition of the Na + -Ca 2+ exchanger. 45 The increase of intracellular calcium in astrocytes adjacent to the hematoencephalic barrier promotes the disruption of this structure, and permits the passage of pro-inflammatory cytokines and cells of the immune system to the brain, aside from contributing to an increase in the intracranial pressure. 46 One of the most important roles played by astrocytes is the removal of diverse neurotransmitters of the synaptic cleft for their ulterior metabolism and, in this way, they regulate the transmission of nerve impulses and avoid neurotoxicity events (induced by excitatory neurotransmitters). This re-uptake of neurotransmitters is accomplished by glutamate aspartate transporter and glutamate transporter-1; the latter being responsible for 90% of the total reuptake of glutamate. 45, 47, 48 During a traumatic event, the expression of both types of transporters diminishes, which promotes excitotoxicity mediated by excitatory neurotransmitters. 45, 48 Disruption of the plasmatic membrane, damage to the hematoencephalic barrier and excitotoxicity produce (together with the mechanisms of neuronal damage and microglial activation) an increase in transforming growth factor-alpha; this cytokine promotes astrogliosis or formation of cerebral scars. 49 Recent research has produced evidence that, analogous to the microglia, the astrocytes can undergo phenotype changes in the presence of specific stimuli. Such phenotypes, named A1 and A2, can promote an inflammatory or neuroprotective state in the central nervous system, respectively.
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The A1 phenotype is primarily induced by interleukin-1, tumor necrosis factor-alpha, C1q and nuclear factor-jB. 50 ,51 A1 astrocytes lose many of their normal functions; decreasing their regulatory role over synapses (including the neurotransmitters reuptake) and their phagocytic capacity. Furthermore, A1 astrocytes become highly neurotoxic and promote the death of neurons that suffered DAI. 51 In contrast, A2 astrocytes promote the secretion of several neurotrophic factors along thrombospondins. This characteristic allows A2 astrocytes to highly promote neuronal repair and neural precursors proliferation. 50 
Effect of the TBI on neurogenesis
As discussed before, exposure to traumatic events leads to the loss of encephalic tissue, including neuronal tissue. This neuronal loss is compensated for by the activation of the neurogenesis process; a phenomenon that has been shown in animal and human models. 52 
Main sites of neurogenesis
Although neurogenesis is a process of high incidence during embryonic development; during the adult stage, this process is restricted to two encephalic areas: the subgranular zone (SGZ) of the dentate gyrus (DG) of the hippocampus and the subventricular zone (SVZ) of the lateral ventricles; the latter contributes the most to the neurogenic process. [53] [54] [55] The cellular precursors responsible for giving rise to new neurons are known as neuronal stem cells (NSC). The NSC are multipotent cells of glial nature that can give rise to different types of intermediate cellular precursors, from which neurons and the different glial cells originate. 55, 56 Despite neurogenesis in SGZ and SVZ leading to the same neuronal production, there are subtle differences in the process occurring in each of these areas. Neurogenesis in SVZ is given from NSC named B cells that, in turn, give way to intermediate precursors named C cells, which will give rise to neuroblasts (A cells) that migrate through the rostral migratory stream toward the olfactory bulb, where they differentiate into interneurons. [55] [56] [57] On the other side, neurogenesis in SGZ starts from NCS (cells type 1), which generate neuronal precursors (cells type 2). The latter give rise to D-type cells, which present the characteristics of a neuron along their development. 58 Exposure to a traumatic event affects the neurogenic process in the adult brain, which, in turn, affects diverse aspects associated with cognition, behavior and recovery of the patient. 52 Although various authors have reported a decrease in neurogenesis after a traumatic event, there is evidence suggesting that neurogenesis in both neurogenic regions (SVZ and SGZ) is induced and potentiated after exposure to traumatic events. 53, 59 This fostering of trauma-mediated neurogenesis can last several days or weeks. 60 
Main neurogenic factors
The neurogenic process, as a complex process and of ample implications at the physiological level, is strongly regulated by the content of the extracellular environment, in particular, by growth factors (GF) and neurotransmitters. 61 Expression of diverse GF, such as brain-derived neurotrophic factor, insulin-like growth factor-I, fibroblasts growth factor-2 (FGF-2), epidermal growth factor (EGF), heparin-binding (HB)-EGF and vascular endothelial GF (VEGF) is implicated determining the size of the neuronal or glial population. [62] [63] [64] Neurotrophins are a family of GF that include brain-derived neurotrophic factor, which promotes the survival of new neuroblasts through tropomyosin receptor kinase B. 59 The brain-derived neurotrophic factor maintains the rate of neurogenesis in the hippocampus of adult mice. 65 Similarly, the participation of insulin-like growth factor-I in the increase of neurogenesis in the hippocampus of adult rats has also been shown. 66 In parallel, the relevance of other GF has been shown, such as FGF-2 and EGF, which have specific effects on neuronal progenitor cells in vivo. 67 It has been observed that stem cells responsive to FGF-2 renew themselves, and have the capacity to generate neurons and glia in vitro; although little is known about the molecular events that regulate de-differentiation of stem cells.
Regarding factors EGF, HB-EGF and VEGF, it is known that the intracerebral ventricular infusion of EGF increases neurogenesis in the SVZ, as occurs with FGF-2. Other observations show that neurogenesis increases in the SVZ and the dentate gyrus after the administration of HB-EGF and VEGF.
Another work identified that T lymphocytes and microglia are important for the maintenance of neurogenesis in the hippocampus and for spatial learning abilities in adults. 68 Together with the GF effects on neurogenesis, neurotransmitters play a regulatory role in this process. 69, 70 It has been shown that multiple neurotransmitters promote the proliferation of NSC in neurogenic zones. 69, 70 Dopamine increases proliferation of NSC by promoting the release of EGF; whereas serotonin promotes neurogenesis through the action of the 5HT 1A receptor, and GABA promotes proliferation of NSC in the SVZ by the action of the GABA A receptor. [71] [72] [73] Glutamate, in turn is responsible for regulating the neurogenesis in the hippocampus, the glutamatergic receptors, such as a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and the metabotropic receptors are involved in the regulation of cellular proliferation. 74, 75 The N-methyl-D-aspartate receptor plays an important role; it has been observed than when the antagonist to this receptor is administered, neurogenesis increases; 76, 77 but if the glutaminergic input to the hippocampus is increased, cellular proliferation increases in the dentate gyrus. Molecular events affect all neurogenic factors, within these are the genetic ones, which induce this process as well as embryonic morphogenesis, among them are the Notch, BMP, Eph/epherins, Noggin and Shh genes, which also participate in regulating the proliferation and differentiation of the main neurogenic zones in the adult brain. 78 Finally, some studies have shown that ovarian steroids are implicated in cellular proliferation of granular precursors. It has been observed that during pregnancy, neurogenesis is stimulated; in the same study, it was observed that the neurogenic events of the forebrain increase, even in female mice that mate with sterile males. 79 
Effect of TBI on neurogenic factors and neural precursors
During and after a TBI, a myriad of events occur in the extracellular environment that affect the neurogenic factors and the neural precursors on which they act.
Exposure to a TBI activates the proliferation of neural precursors in neurogenic zones (SVZ and SGZ) and the surrounding zone to the injury. 52, 60, 80 It has been proposed that the cellular proliferation in the surrounding zone could be due to the migration of NSC from neurogenic regions. This migration seems to be mediated by the release of cytokines, such as the stem cells factor and the stromal cells 1a-derived factor; these cytokines are released by the damaged neurons in the impact zone. 81, 82 The NCS that proliferate in the presence of a TBI become fully functional neurons and play an important role in the recovery of motor deficits induced by the TBI. 83, 84 Proliferation and differentiation of NCS depends largely from the neurogenic factors released in the area affected by the TBI. Exposure to cranioencephalic trauma events increases the concentration of FGF-2 in the DG, and of basic fibroblast growth factor in the DG and SVZ; which, in turn promotes cellular proliferation and differentiation in these areas. 85, 86 In parallel, TBI events promote the release of VEGF. This growth factor promotes neurogenesis, although to a lesser extent than gliogenesis. 87 In contrast, evidence exists that hypoxic events, such as those produced by TBI-induced secondary damage, promote an increase in the encephalic levels of erythropoietin, which can favor neurogenesis in the DG and promote recovery of spatial memory. 88, 89 In contrast to FGF-2, VEGF and basic fibroblast growth factor, insulin-like growth factor-1 diminishes in concentration in the event of a trauma, a condition that would imply a reduction not only of neurogenesis, but also of cell survival and migration of neuroblasts; which are processes that also involve this molecule. 66, 90, 91 In addition to the change in the concentration of diverse neurogenic factors, exposure to traumatic events leads to a deregulation of the concentrations of diverse neurotransmitters that also regulate neurogenesis.
Evidence exists that trauma deregulates dopamine concentrations, elevating its concentration during the first hours after the traumatic event, followed by a decrease in the concentration with a duration of up to 2 weeks; the latter is related to cognitive and behavioral deficits. 92 Serotonin secretion is increased after a TBI, together with a reduction in the expression of the SERT transporter; both factors promote the extracellular increase in serotonin concentration, which in a contradictory way is related to the development of depression. 93, 94 Neurodegeneration associated with TBI As aforementioned, the set of immunological factors that become activated in the brain area by the occurrence of a TBI generate a pro-inflammatory state that can last for years; this condition promotes a lasting change in the encephalic extracellular environment, which is a key factor for the development of CTE. It has been suggested that a constant proinflammatory state is related to neurodegeneration; this process is defined as any pathological condition mainly affecting the neurons. 95 The neurodegenerative process associated with inflammation is related not only to CTE, but also to neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. All these diseases have characteristic histological factors associated with them, such as the deposition of amyloid beta plaques and the tau protein; which are structures defined as markers of neurodegeneration. 96 
Neurodegeneration mechanisms
Previously, we mentioned that neuroinflammation plays a very important role in the start of the neurodegeneration associated with CTE. During an event of this nature, cells of the microglia will start to be activated, as well as the infiltration of leukocytes to the encephalic region resulting from the release of damage-associated molecular patterns caused by tissular damage. 97 This, in turn, will promote the polarization of microglial phagocytic cells to a pro-inflammatory/M1-like phenotype, producing an increase in pro-inflammatory mediators that will worsen the existent inflammatory state. 98 TBI and the subsequent neuroinflammatory event will also induce deregulation of other encephalic mechanisms, such as expression of nicotinamide adenine dinucleotide oxygenase 2 by microglia. Although the expression of this enzymatic complex is essential for the defense of the organism, cellular proliferation and signaling in the microglia, recent evidence has shown that the overexpression of nicotinamide adenine dinucleotide oxygenase 2 induced by a constant neuroinflammatory state induces neurotoxic effects and increases the existing inflammation state. 99 Recent studies have shown that after a TBI there is an increase in the expression of the tau protein and of the precursor of the amyloid beta protein, consequently, in the amount of deposits in the cerebral tissue, which can last for hours after the traumatic event, and can accumulate in the case of multiple traumatic events. 4 ,100-102 However, the mechanisms by which the amyloid beta protein accumulates have not been elucidated yet, and it has been proposed that it is able to promote both nicotinamide adenine dinucleotide phosphate activity and the lipidic peroxidation process in astrocytes, in turn favoring the production of reactive oxygen species; thereby subjecting the neighboring neurons to oxidative stress, leading to neurodegeneration by producing tau protein-mediated neurotoxicity and the accumulation of more amyloid beta protein. [103] [104] [105] In addition, the tau protein, responsible for stabilizing the microtubules of the cytoskeleton, has been proven to play a strong role in the neurodegeneration associated with CTE. 106 Changes in tau protein are associated with its accumulation and deposition, as well as with changes in the cytoskeletal structure of neurons 107 that, in turn, will produce alterations in the axolemma, avoiding the binding of motor molecules, such as kinesins promoting the loss of synapses, defects in axonal transport and neuroinflammation. [108] [109] [110] [111] It has been proposed that this structural change is the main pathogenic mechanism of the tau protein in neurodegeneration. 106, 107 The amyloid beta and tau proteins work concomitantly to promote neurodegeneration, influencing the accumulation of amyloid beta plaques and tau dysfunction, either by promoting its hyperphosphorylation or through alternative mechanisms. 105, 107 It is known that the accumulation of extracellular tau deposits (neurofibrillary tangles) can promote tau dysfunction in surrounding healthy neurons, thereby propagating the tau-mediated neurodegeneration. 106 This leads to accumulation of neurofibrillary tangles, which are characteristic formations of CTE. 101, 112, 113 Although tau and the amyloid beta protein play a central role in the neurodegeneration produced in CTE patients, many other molecules are involved in this process. The TAR DNA-binding protein 43 (TDP-43) is a nuclear transcriptional repressor, capable of binding to DNA and RNA molecules. In neuronal cells of the brain and the spinal cord, TDP-43 regulates the expression of low molecular weight neurofilaments. 114 In several neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer's disease and frontotemporal lobe dementia (among some others), cellular inclusions of TDP-43 are a constant finding. These cellular inclusions are composed of phosphorylated, ubiquitinated and cleaved TDP-43 aggregates found in the cytoplasm. 114, 115 In patients who suffer from CTE, TDP-43 can be found in the frontal and temporal cortices, basal ganglia, the brainstem, and spine motor neurons in the spinal cord. In particular, the TDP-43 inclusions in the spinal cord can promote motor disabilities, such as weakness, atrophy spasticity and fasciculations. [114] [115] [116] It is yet unknown if the pathology produced by TDP-43 aggregates is caused by a loss of function or a gain of function, as well as the precise mechanisms underlying its malfunctioning. 115 Cognitive and behavioral deficits associated with CTE As a result of the brain damage caused in diverse cortical and subcortical structures in a chronic manner, and because of the sustained neurodegeneration resulting from the multiple traumatic events that lead to CTE, patients present diverse cognitive and behavioral deficits. 113 These behavioral and cognitive alterations are commonly observed in individuals that engage in some type of contact sport in a constant manner, such as boxers, professional NFL players and war veterans exposed to one or multiple blast artifacts. 112, 117, 118 The first symptoms of cognitive decline include memory and learning alterations, as well as of the executive function (problems with planning, organization, judgment), difficulties in talking, headaches, attention deficits, reduced psychomotor activity, visual disability and so on. 6, 116, 118, 119 Regarding behavioral changes, symptoms comprise problems in controlling impulses, disinhibition, anxiety, depression, apathy, even paranoia, aggression and an increase in violence. 4, 6, 113, 118 Constant exposure to TBI events worsens the cognitive deficit of the exposed individual, presenting, in severe cases, tremors, dizziness, deafness and muscular weakness. Usually, the severity of the symptoms is directly related to the time that the individual practiced some contact sport or to the number of traumatic events they were exposed to. 113, 118 Symptoms manifest years, even decades, after the repetitive TBI, when neurodegeneration is sufficiently severe and progresses with the course of the disease. 119 The neurodegeneration associated with CTE is mainly found in the frontal, entorhinal, parietal and temporal cortices, as well as in subcortical areas, such as the hippocampus, the amygdala and the thalamus. 6, 118 It has been shown that several deficiencies in the brain regions damaged during TBI can promote one or several cognitive and behavioral deficits associated with CTE. The frontal cortex with its different divisions (orbitofrontal, dorsolateral and medial-dorsal/ cingulate) are involved in memory, attention, working memory, personality, emotions control and social behavior, among other processes; damage to these zones can result in memory, attention, decisionmaking and social reasoning deficits, as well as depression, apathy, impulsiveness so on. 120 The entorhinal cortex and the hippocampus are involved in spatial memory cortex and fear processing; changes in their function can give rise to deficits in these functions. [121] [122] [123] Finally, the amygdala is closely associated with the limbic component; influencing anger, fear, sadness and recognizing foreign emotions; lesions in these areas can affect these functions.
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Conclusion
The generation and progression of CTE is highly mediated by inflammatory factors produced by repeated brain traumas that accordingly promote the increase of the damage and perpetuate the proinflammatory state, affecting neurogenic processes and fostering diverse proteinopathies that lead to neurodegeneration of specific brain areas and resulting in cognitive and behavioral deficits that affect the quality of life of those affected by it.
